These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 25527127)

  • 1. Disappointing response to dapsone as second line therapy for primary ITP: a case series.
    Oo T; Hill QA
    Ann Hematol; 2015 Jun; 94(6):1053-4. PubMed ID: 25527127
    [No Abstract]   [Full Text] [Related]  

  • 2. Dapsone for immune thrombocytopenic purpura in children and adults.
    Patel AP; Patil AS
    Platelets; 2015; 26(2):164-7. PubMed ID: 24512442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dapsone for chronic idiopathic thrombocytopenic purpura in children and adults--a report on 90 patients.
    Damodar S; Viswabandya A; George B; Mathews V; Chandy M; Srivastava A
    Eur J Haematol; 2005 Oct; 75(4):328-31. PubMed ID: 16146539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of dapsone as a second-line treatment in non-splenectomized adults with immune thrombocytopenic purpura.
    Vancine-Califani SM; De Paula EV; Ozelo MC; Orsi FL; Fabri DR; Annichino-Bizzacchi JM
    Platelets; 2008 Nov; 19(7):489-95. PubMed ID: 18979360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dapsone treatment in a girl with severe chronic thrombocytopenic purpura. Does it work? Do not touch it!
    Pusiol A; Nocerino A; Passone E; Tenore A
    Minerva Pediatr; 2012 Oct; 64(5):545-7. PubMed ID: 22992536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presentation and outcome of idiopathic thrombocytopenic purpura in a single Australian centre.
    Choi PY; Gordon JE; Harvey M; Chong BH
    Intern Med J; 2012 Jul; 42(7):841-5. PubMed ID: 22805691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dapsone for refractory chronic idiopathic thrombocytopenic purpura.
    Hernández F; Linares M; Colomina P; Pastor E; Cerveró A; Pérez A; Perella M
    Br J Haematol; 1995 Jun; 90(2):473-5. PubMed ID: 7794776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Idiopathic thrombocytopenic purpura. A retrospective evaluation of 68 patients].
    Treppendahl MB; Nielsen OJ
    Ugeskr Laeger; 2004 Sep; 166(39):3393-7. PubMed ID: 15515392
    [No Abstract]   [Full Text] [Related]  

  • 9. Rituximab in auto-immune haemolytic anaemia and immune thrombocytopenic purpura: a Belgian retrospective multicentric study.
    Dierickx D; Verhoef G; Van Hoof A; Mineur P; Roest A; Triffet A; Kentos A; Pierre P; Boulet D; Bries G; Lê PQ; Janssens A; Delannoy A
    J Intern Med; 2009 Nov; 266(5):484-91. PubMed ID: 19549092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diaminodiphenyl sulfone therapy for refractory idiopathic thrombocytopenic purpura--long-term effectiveness and possible mechanisms].
    Hirasawa A; Sato T; Kawabuchi Y; Nishikawa T; Chiba S; Wakabayashi Y
    Rinsho Ketsueki; 1999 Oct; 40(10):1068-73. PubMed ID: 10565223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age old dapsone in the treatment of idiopathic thrombocytopenic purpura--a case report with review.
    Kundu R; Sethi N; Ghose A; Chaudhary R
    Am J Ther; 2013; 20(6):e723-5. PubMed ID: 21822117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effects of corticosteroid treatment on immune thrombocytopenia under new diagnostic criteria].
    Guo L; Ma DX; Hou M
    Zhonghua Nei Ke Za Zhi; 2010 Dec; 49(12):1020-3. PubMed ID: 21211359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of dapsone as second line therapy for adult immune thrombocytopenia: A retrospective study of 42 patients.
    Estève C; Samson M; Guilhem A; Nicolas B; Leguy-Seguin V; Berthier S; Bonnotte B; Audia S
    PLoS One; 2017; 12(10):e0187296. PubMed ID: 29084292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dapsone in treatment of chronic idiopathic thrombocytopenic purpura in adults.
    Dutta TK; Goel A; Ghotekar LH; Hamide A; Badhe BA; Basu D
    J Assoc Physicians India; 2001 Apr; 49():421-5. PubMed ID: 11762611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dapsone for primary immune thrombocytopenia in adults and children: an evidence-based review.
    Rodrigo C; Gooneratne L
    J Thromb Haemost; 2013 Nov; 11(11):1946-53. PubMed ID: 23927583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous rash and dapsone-induced hypersensitivity syndrome a common manifestation in adult immune thrombocytopenia. Presentation and outcome in 16 cases.
    Sauvetre G; MahÉvas M; Limal N; Guillaud C; Khellaf M; Bierling P; Languille L; Delbos F; Noizat-Pirenne F; Michel M; Godeau B
    Am J Hematol; 2015 Oct; 90(10):E201-2. PubMed ID: 26120067
    [No Abstract]   [Full Text] [Related]  

  • 17. [A clinical study of 103 idiopathic thrombocytopenic purpura].
    Fan Y; Chang NB; Xing BL; Li YM; Pei L; Li JT
    Zhonghua Nei Ke Za Zhi; 2008 Apr; 47(4):313-5. PubMed ID: 18843957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dapsone salvage therapy for adult patients with immune thrombocytopenia relapsed or refractory to steroid and rituximab.
    Zaja F; Marin L; Chiozzotto M; Puglisi S; Volpetti S; Fanin R
    Am J Hematol; 2012 Mar; 87(3):321-3. PubMed ID: 22190262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dapsone for idiopathic thrombocytopenic purpura.
    Linares M; Cervero A; Pastor E; Colomina P
    Am J Hematol; 1994 Aug; 46(4):371-2. PubMed ID: 8037195
    [No Abstract]   [Full Text] [Related]  

  • 20. [The impact of platelet membrane autoantibodies on high-dose dexamethasone therapy in patients with idiopathic thrombocytopenic purpura].
    Wang R; Qin P; Ji XB; Hou M
    Zhonghua Xue Ye Xue Za Zhi; 2009 Sep; 30(9):619-21. PubMed ID: 19954623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.